Study on Preventing Bloodstream Infections from Central Venous Catheters in ICU Patients in China

What this Trial Is About

Researchers are studying central venous catheter-related bloodstream infections CLABSI in intensive care units ICUs across China. CLABSI is a common and serious infection linked to central venous catheters used in critical care, causing extended hospital stays and increased costs. The study aims to understand the current rates of CLABSI and the factors influencing these infections, especially following changes in the healthcare environment during the COVID-19 pandemic, to help improve prevention strategies nationwide. This observational study focuses on adult ICU patients who have central venous catheters expected to remain in place for more than 48 hours. Patients are closely monitored for the occurrence of CLABSI, and data are collected prospectively across multiple ICUs in China. The study will run for an average of six months to observe and record infection rates and related factors. Participants will be admitted to the ICU with a central venous catheter and followed to track infection incidence. Researchers will collect relevant clinical information and monitor the patients throughout their ICU stay. The main outcome measured is the rate of CLABSI during the study period. This information will help guide future efforts to reduce catheter-related infections in critical care settings.

Epidemiological Investigation of Central Venous Catheter-related Bloodstream Infections in Icus in China